Search for Clinical Trial Results

Adenocarcinoma, Papillary - 3 Studies Found

Status Study
Not yet recruiting Study Name: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Condition:
  • Adenoid Cystic Carcinoma
  • Adnexal Carcinoma
  • Apocrine Carcin
    Date: 2016-11-30
    Interventions:
    • Other: Laboratory Biomarker Analysis

Active, not recruiting Study Name: Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Condition:
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Seromucinous Carcinoma
  • Drug: Everolimus Given PO
Active, not recruiting Study Name: Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
Condition:
  • Deleterious BRCA1 Gene Mutation
  • Deleterious BRCA2 Gene Mutation
  • Drug: Cediranib Maleate Given